financetom
Personal Finance
financetom
/
Personal Finance
/
Research Alert: CFRA Reiterates Buy Opinion On Shares Of Nutanix, Inc.
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Research Alert: CFRA Reiterates Buy Opinion On Shares Of Nutanix, Inc.
Mar 4, 2024 11:01 PM

01:00 PM EST, 02/29/2024 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows:

We raise our target to $71 from $47 on a P/S of 7.5x, above its three-year average on good sales execution and a favorable deal pipeline, using our next-12-month sales estimate of $2.3B. We lift our FY 24 EPS view to $1.07 from $0.95 and FY 25's to $1.33 from $1.21. NTNX posted Q2 sales of $565.2M, above consensus by $14.8M, while non-GAAP EPS of $0.46 beat by $0.17. Revenue rose 16.2% Y/Y from solid Subscription revenue growth (+18% Y/Y) as ACV billings outperformed, up 23% Y/Y, from higher-than-anticipated renewals. We note NTNX's commentary around a continued uncertain macro environment, and longer average sales cycles, which likely impacted contract duration of 2.8 years in Q2, lower than Q1. However, these results reflect the firm's strong execution in securing and keeping pace with renewals and expansion deals, as well as maintaining healthy pricing levels in spite of these challenges. Its upbeat guidance and a higher mix of large deals in the pipeline further support our positive view of the business.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Research Alert: CFRA Reiterates Strong Buy Opinion On Shares Of Eli Lilly And Company
Research Alert: CFRA Reiterates Strong Buy Opinion On Shares Of Eli Lilly And Company
Apr 30, 2024
10:30 AM EDT, 04/30/2024 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: We raise our target price to $906 from $885, reflecting 54.6x our 2025 EPS, justified by LLY's robust growth outlook. We lift our 2024 EPS estimate to $13.54 from $12.50...
Research Alert: CFRA Reiterates Buy Opinion On Shares Of Welltower Inc.
Research Alert: CFRA Reiterates Buy Opinion On Shares Of Welltower Inc.
Apr 30, 2024
10:35 AM EDT, 04/30/2024 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: We raise our target price by $8 to $110, applying a forward P/FFO of 26.5x our 2024 FFO estimate, a premium to WELL's 21.2x five-year average multiple due to the...
Research Alert: CFRA Keeps Buy Opinion On Shares Of Nxp Semiconductors N.v.
Research Alert: CFRA Keeps Buy Opinion On Shares Of Nxp Semiconductors N.v.
Apr 30, 2024
10:30 AM EDT, 04/30/2024 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: We increase our 12-month target to $290 from $250 on a P/E of 18.5x our 2025 EPS view, above five-year historical forward average to reflect our view of bottoming fundamentals....
Research Alert: CFRA Keeps Buy Opinion On Shares Of Eog Resources, Inc.
Research Alert: CFRA Keeps Buy Opinion On Shares Of Eog Resources, Inc.
Apr 30, 2024
10:45 AM EDT, 04/30/2024 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: Our 12-month target price of $153, raised $24, reflects a 5.8x multiple of enterprise value to projected 2025 EBITDA, slightly above EOG's historical forward average. We lift our 2024 EPS...
Copyright 2023-2025 - www.financetom.com All Rights Reserved